SIP 2017 - Key Statement
Prof. Audun Stubhaug – Oslo University Hospital, Norway
"High quality registers are needed both to gain new knowledge about pain and for continuous evaluation of resource allocation and treatment results. Linking epidemiological studies and national health registers is a powerful way to get important information for politicians and health care providers."
Prof. Audun Stubhaug
Professor, Head of department
Oslo University Hospital and University of Oslo
Individual level national registers are unexploited sources for gaining new information about the societal impact of pain. By linking individual data from registers like the prescription register, the patient register, the sick leave/pension database and the primary care register with high quality epidemiological studies/registers unique opportunities arise. Longitudinal data may detect causal relationships that can guide preventive strategies/interventions. Furthermore, resource allocation, and disease trajectories can be studied. Both politicians and health need these high quality register data to improve health care and reduce the societal impact of pain.
Audun Stubhaug is Professor of anesthesiology at University of Oslo and head of Department of Pain Management and Research, at Oslo University Hospital, one of the largest multidisciplinary pain centres in Scandinavia. Stubhaug has been active in pain research and pain treatment for 25 years and has more than 150 publications. His research covers human experimental pain and pain mechanisms, studies of pharmacological treatment, the studies of transition from acute to chronic pain. He has the last 10 years been in the lead of a large epidemiological study of pain (Tromsø Pain Study, N=20 000) with detailed information on both pain patients and healthy individuals. By linking individual data with national registers, his group has started the search for finding new causal relationships and he aims to find both clinical and genetic identifiable risk factors, and potentially develop preventive treatment. Stubhaug is a frequent lecturer at international congresses, and he is in the editorial board of several journals.